Metrion Biosciences Cardiac Safety Screening Services
Metrion Biosciences Cardiac Safety Screening Icon Large 01 01

Cardiac Safety Screening Services

Metrion Biosciences is a reliable specialist ion channel screening provider and a longstanding member of the Safety Pharmacology Society, the HESI Cardiac Committee and the HTS-sub-team for Automated Patch Clamp studies. Metrion provides clients with high quality assay data to help determine the cardiac liability of their compounds early in the drug discovery process. Metrion offers screening services against a premium panel of validated CiPA (Comprehensive in vitro Proarrhythmia Assay) compliant human cardiac ion channel screening assays, including hERG and iPSC-derived cardiomyocytes.

Metrion Biosciences Translational Assays Services 1920x1440 1
Metrion Biosciences Translational Assays Icon Large 01

Neuroscience Screening Assays

Metrion also offers a range of phenotypic neuroscience assays to screen compounds against native and iPSC-derived neurons for neurotoxicity testingmechanism-of-action studies and species selectivity profiling,  which can be used to translate compounds towards preclinical studies.  Neuroscience assays include both manual patch clamp and microelectrode array (MEA) recordings.

Recommended publications

White Papers
Application notes
Publications
Posters
Wave Background thinner 01 1
Metrion Cardiac Safety Screening Icon 01

Contact Metrion’s Safety Pharmacology Experts to discuss your project

What are your specific ion channel and assay needs?

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.

Contact us